RYTM
RHYTHM PHARMACEUTICALS, INC.
NASDAQ · Healthcare · Biotechnology · US
$110.68
+28.04%Margins
Gross margin
88.2%
EBITDA margin
-61.7%
EBIT margin
-66.7%
Net margin
-69.0%
FCF margin
-29.6%
-96.2%
Return on equity
-43.7%
Return on assets
-91.3%
Return on invested capital
0.64x
Asset turnover
-$81.8M
Cash from operations
$4.63
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2026